» Articles » PMID: 38235710

Efficacy and Safety of Modified Valsalva Maneuver for Treatment of Paroxysmal Supraventricular Tachycardia: a Meta-analysis

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2024 Jan 18
PMID 38235710
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare the efficacy and safety of the modified versus standard Valsalva maneuver in the treatment of paroxysmal supraventricular tachycardia (PSVT).

Methods: The PubMed, Embase, Web of Science, CNKI, WanFang Data, and VIP electronic databases were searched to identify studies comparing the modified and standard Valsalva maneuvers in the treatment of PSVT from database inception to 1 May 2023. Two reviewers independently screened the literature, extracted the data, and assessed the risk of bias of all included studies.

Results: Nineteen randomized controlled trials involving 2527 patients with PSVT were included. The overall rate of cardioversion was higher in the modified than standard Valsalva group (risk ratio [RR] = 1.80, 95% confidence interval [CI] = 1.61-2.01), as was the success rate of cardioversion after a single Valsalva maneuver (RR = 2.05, 95% CI = 1.74-2.41). There was no statistically significant difference in adverse reactions between the two groups (RR = 1.07, 95% CI = 0.82-1.38).

Conclusion: Current evidence suggests that the modified Valsalva maneuver can significantly improve the success rate of cardioversion in patients with PSVT without increasing adverse reactions. The modified Valsalva maneuver is therefore worth promoting and should be considered as a routine first treatment. 2023100092.

Citing Articles

Managing supraventricular tachyarrhythmia in pregnant patients within the emergency department.

Pan D, Chen Z, Chen H Front Cardiovasc Med. 2024; 11:1517990.

PMID: 39720210 PMC: 11666441. DOI: 10.3389/fcvm.2024.1517990.


Valsalva Maneuver Versus Carotid Sinus Massage for Supraventricular Tachycardia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Alfehaid A, Almutairi O, Albloushi M, Alahmad A, Hasan M, Alawadhi O Cureus. 2024; 16(9):e70064.

PMID: 39449910 PMC: 11499895. DOI: 10.7759/cureus.70064.

References
1.
Smith G . A modified Valsalva manoeuvre results in greater termination of supraventricular tachycardia than standard Valsalva manoeuvre. Evid Based Med. 2016; 21(2):61. DOI: 10.1136/ebmed-2015-110357. View

2.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

3.
Michaud A, Lang E . Leg Lift Valsalva Maneuver for Treatment of Supraventricular Tachycardias. CJEM. 2016; 19(3):235-237. DOI: 10.1017/cem.2016.341. View

4.
Ceylan E, Ozpolat C, Onur O, Akoglu H, Denizbasi A . Initial and Sustained Response Effects of 3 Vagal Maneuvers in Supraventricular Tachycardia: A Randomized, Clinical Trial. J Emerg Med. 2019; 57(3):299-305. DOI: 10.1016/j.jemermed.2019.06.008. View

5.
Wang W, Jiang T, Han W, Jin L, Zhao X, Guo Y . Efficacy and economic benefits of a modified Valsalva maneuver in patients with paroxysmal supraventricular tachycardia. World J Clin Cases. 2020; 8(23):5999-6008. PMC: 7723698. DOI: 10.12998/wjcc.v8.i23.5999. View